SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,821 | -8.9% | 345 | -14.0% | 0.01% | -11.1% |
| Q2 2023 | $45,922 | -16.9% | 401 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $55,270 | +25.6% | 401 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $44,000 | +46.7% | 401 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $30,000 | -11.8% | 401 | -7.6% | 0.01% | 0.0% |
| Q1 2022 | $34,000 | -20.9% | 434 | -8.4% | 0.01% | -11.1% |
| Q4 2021 | $43,000 | -2.3% | 474 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $44,000 | +25.7% | 474 | +4.6% | 0.01% | +22.2% |
| Q2 2021 | $35,000 | – | 453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |